title: Modelling olanzapine-induced weight gain in rats.
abstract: The second-generation antipsychotic drug olanzapine has become a widely prescribed drug in the treatment of schizophrenia and bipolar disorder. Unfortunately, its therapeutic benefits are partly outweighed by significant weight gain and other metabolic side effects, which increase the risk for diabetes and cardiovascular disease. Because olanzapine remains superior to other antipsychotic drugs that show less weight gain liability, insight into the mechanisms responsible for olanzapine-induced weight gain is crucial if it is to be effectively addressed. Over the past few decades, several groups have investigated the effects of olanzapine on energy balance using rat models. Unfortunately, results from different studies have not always been consistent and it remains to be determined which paradigms should be used in order to model olanzapine-induced weight gain most accurately. This review summarizes the effects of olanzapine on energy balance observed in different rat models and discusses some of the factors that appear to contribute to the inconsistencies in observed effects. In addition it compares the effects reported in rats with clinical findings to determine the predictive validity of different paradigms.
authors.affiliation: Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
authors.forename: E M
authors.initials: EM
authors.lastname: van der Zwaal
authors.forename: S K
authors.initials: SK
authors.lastname: Janhunen
authors.forename: S E
authors.initials: SE
authors.lastname: la Fleur
authors.forename: R A H
authors.initials: RA
authors.lastname: Adan
mesh_terms: D000818:Animals; D001569:Benzodiazepines / Q000009:adverse effects*; D004195:Disease Models, Animal; D002149:Energy Intake / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D000077152:Olanzapine; D011237:Predictive Value of Tests; D051381:Rats; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D001569:Benzodiazepines; D000077152:Olanzapine